Objective: Attention-deficit/hyperactivity disorder (ADHD) has been associated with a broad range of physical health problems, including cardiometabolic, neurological and immunological conditions. Determining whether ADHD plays a causal role in these associations is of great importance for treatment and prevention but also because comorbid health problems further increase the serious social and economic impacts of ADHD on individuals and their families.
Key Message
• Epidemiological studies have reported observational associations between ADHD and adult onset physical health outcomes.
• Mendelian Randomization can be used to assess causal associations for ADHD on health outcomes that would traditionally require long term follow-up and may suffer confounding • We found that genetic liability for ADHD was associated with coronary artery disease and there was evidence for a bidirectional association between genetic liability for ADHD and childhood obesity
• Multivariable mendelian randomization suggests that the link between genetic liability and coronary artery disease might partially act through childhood obesity but was independent of smoking heaviness
• There was little evidence of a causal of ADHD on other cardiometabolic and immunological diseases.
INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental condition with an onset typically in early childhood and a worldwide prevalence of about 5% in school-aged children and about 2-3% in adults (1, 2). In 65% of children diagnosed with ADHD symptoms impairment persist into adulthood and can be associated with psychiatric problems, social and occupational difficulties (3). ADHD is associated with higher mortality and morbidity rates(4) and a broad range of physical health problems. These include metabolic problems (including obesity and type 2 diabetes mellitus), cardiovascular problems (such as hypertension (5) and other risk factors for cardiovascular disease (CVD)), neurological problems (including epilepsy and migraine(6)), allergic/inflammatory disorders (including asthma (6-8), allergic rhinitis and coeliac disease)(6) and some types of cancer.
Determining whether ADHD causally contributes to these health problems is of great importance because comorbid health problems further increase the serious social and economic impacts of ADHD on individuals and society (9, 10) . However, there are multiple possible explanations for the association between ADHD and physical health problems:
1. ADHD could cause physical health problems by increasing risk for an unhealthy lifestyle and risk behaviours, e.g. via smoking, excess alcohol consumption, sedentary lifestyle and dietary choices all of which appear to influence physical ill-health.
2. ADHD could be associated with physical health outcomes because of shared genetic variants (pleiotropic effects).
3. Shared environmental risk (pre-and postnatal factors) may confound the association between ADHD and poor physical health.
Causal relationships between ADHD and physical health problems cannot be resolved by conventional observational studies because of issues including selection bias, reverse causation and residual confounding ( 1 1 ) . However recent advances in genome-wide association studies enable the use of genetic variants strongly associated with ADHD ( 1 2 ) as proxies (instrumental variables) for the life-time risk of ADHD and to study causal effects of genetic liability for ADHD on physical health outcomes using Mendelian randomization (MR).
The rationale behind MR is that genetic variants can be used as theoretically un-confounded proxies for that exposure since they are determined randomly at conception and segregated through to viable offspring independently of environmental influences(13, 1 4 ) .
In this study, we aim to investigate causal relationships between genetic liability for ADHD and metabolic, cardiovascular, inflammatory and neurological conditions previously observed to be associated with ADHD, using a two-sample MR design.
METHODS

Two-sample MR
MR utilizes genetic variants as proxies for an exposure of interest and allows the estimation of an un-confounded causal association between exposure and outcome, if certain assumptions(13) hold true:
1. The genetic variants are strongly associated with the exposure of interest.
2. The genetic variants are independent of confounders of exposure and outcome.
3. The genetic variants do not affect the outcome except through the exposure (exclusion restriction criterium). If they affect the outcome through other pathways, this is called horizontal pleiotropy.
Within a two-sample MR approach GWAS summary statistics are used to assess both genetic variant-exposure and genetic variant-outcome associations. All steps of the twosample MR performed here are explained in more detail below and summarized in Figure 1 .
Analyses were conducted using the TwoSampleMR package version 0.4.14 for R (version 3.4.1).
ADHD GWAS (exposure)
Genetic variants associated with ADHD (the exposure) we identified in the summary statistics for European ancestry participants from the combined PGC+iPSYCH metaanalysis of ADHD including 19 099 cases and 34 194 controls (12). Log odds ratio (OR) and standard error estimates for thirteen SNPs with p<1x10 -7 were extracted after clumping (r 2 =0.001 within 10,000kb) and removal of palindromic sequences (Table S1 in the Supplement).
GWAS on physical health problems (outcome)
We used freely available GWAS summary statistics from predominantly European ancestry populations on physical health problems that have been previously reported as being associated with ADHD ( 6 -8 Table 1 and Table S2 ), because of the strong link between ADHD and smoking behaviour.
An exploratory analysis was conducted for metabolic markers derived from the 2016 GWAS from Kettunen et al., since they have been implicated as risk factors for CAD and obesity (26). GWAS derived from UK biobank by the Neale lab (http://www.nealelab.is/uk-biobank)
are reported on a risk difference scale and were transformed onto the log OR scale (see supplementary material). All outcome GWAS are thought to be independent of the PGC+iPSYCH sample. The GWAS for coronary artery disease and myocardial infarction are derived from a mixed population sample with 77% white European participants.
SNPs associated with ADHD were extracted from the respective outcome GWAS (Table   S3) . If SNPs could not be extracted (due to differences in genotype chips, reference panels or imputation methods between studies), we searched for proxies using SNiPA with r 2 =0.9
(https://snipa.helmholtz-muenchen.de/snipa3/).
Assessing instrument strength
Instrument strength (assumption (1) of MR) was assessed using the F-statistic, which is equal to the ratio of the mean square of the model estimates to the mean square of the model error for each genetic variant. If F>10, as a rule of thumb, results should not suffer from weak instrument bias(27).
Estimating causal effects using a two-sample MR approach
The SNP-exposure and SNP-outcome associations were assessed using an inversevariance weighted approach (IVW), a weighted median approach and MR-Egger regression.
All three methods require different assumptions on instrument validity to be true and should be interpreted alongside each other. IVW assumes all instruments are valid with no horizontal pleiotropy and therefore restricts the regression intercept to zero (28). Weighted median provides a causal estimate if at least 50% of instruments can be considered valid (29). MR-Egger relaxes the assumption that the outcome is affected only via the exposure and includes a random intercept coefficient in the weighted regression, which reduces power compared to the other two methods. The intercept coefficient is then equivalent to the overall pleiotropic effect and the slope coefficient displays the causal estimate under the assumption that the pleiotropic effects of the genetic variants on the outcome are not proportional to the variants' effects on the risk factor of interest (30).
Odds ratios (OR) for associations between binary exposures and binary outcomes in twosample MR studies are interpreted as the OR for outcome per unit increase in the log odds ratio of the exposure.
We present multiple testing uncorrected estimates (while acknowledging the number of correlated phenotypes that have been tested) and focus on consistent results across MR methods to assess the strength of evidence for a causal effect. 
Assessing heterogeneity
Bidirectional MR
When a potentially causal effect of genetic liability for ADHD on a health outcome was detected, we further investigated the direction of effect in a bidirectional MR analysis. In this case, both the effect of the exposure genetic variants on the outcome and the outcome genetic variants to exposure are assessed to inform about the direction of an effect that could be cross-generational. We identified independent genetic variants for the relevant outcomes (childhood obesity (p<1x10 -6 ) (16) and CAD (p<5x10 -8 ) (17)) from their respective GWAS summary statistics and used the steps described before to perform a two-sample MR.
Multivariable MR
Two Multivariable MR (MVMR) analysis were conducted to assess the effects of genetic liability for ADHD together with genetic liability for childhood obesity or lifetime smoking heaviness on CAD (32). MVMR is an extension of MR that can be used to estimate the causal effects of multiple exposures on one outcome simultaneously ( Figure 2 ). MVMR is explained in more detail elsewhere ( 3 3 ) .
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RESULTS
Estimates of causal effects of ADHD on physical health outcomes Cardiometabolic disease and risk factors
Instrument strength for IVW-MR was assessed using F-statistics for the SNP-exposure association (Table S4 ) and indicated good instrument strength. MR results are shown in ), which might undermine the ability to detect a causal relationship.
Neurological diseases
There was little evidence of a causal effect of ADHD genetic liability on migraine (OR:0.94 (95% CI:0.84,1.05)) or epilepsy (OR:1.01 (95% CI:1.00,1.02)). 
Immunological diseases and cancer
Bidirectional MR for coronary artery disease and childhood obesity
To further investigate the direction of observed effects, we performed bidirectional MR to examine the effect of genetic liability for CAD and childhood obesity on ADHD (Table 2 ).
There was little evidence of a causal effect of genetic liability for CAD on ADHD with an IVW estimate of 0.98 (95% CI:0.92,1.04). However, there was some evidence of a causal association of genetic liability for childhood obesity on ADHD with IVW OR=1.15 (95% CI:1.05,1.25) and weighted median OR=1.10 (95% CI:1.01,1.20). MR Egger estimates were directionally consistent and there was little evidence of heterogeneity or horizontal pleiotropy (MR Egger intercept: 1.00 (95% CI:0.88,1.13)).
( Table 2 here)
Exploratory analyses: Estimates of a causal effect of ADHD on metabolic markers
The two-sample MR of ADHD on metabolic markers suggested little evidence for a causal effect on any of these markers. (Table S7 ).
Multivariable MR to test for a potential mediating effect of childhood obesity and lifetime smoking
Obesity and smoking are established risk factors for CAD (34) that are strongly associated with ADHD (35) , (36) and hence may be mediating the association between the genetic liability for ADHD and CAD. When genetic variants for ADHD and childhood obesity were simultaneously entered in the MVMR model, the direct causal effect of the genetic liability for ADHD on CAD was attenuated to 1.06 (95% CI:0.95,1.17), whereas the effect of the genetic liability for childhood obesity on CAD remained stable (OR:1.14(95% CI:1.08,1.20)) (Table   S8 ), which supports a mediating role of childhood obesity. The causal effect of genetic liability for ADHD on lifetime smoking heaviness was 1.07 (95%CI:1.04,1.10). When genetic variants for ADHD and lifetime smoking heaviness were simultaneously entered in the MVMR model, the direct causal effect of the genetic liability for ADHD on CAD remained stable (OR:1.10 (95% CI:1.00,1.21), whereas the effect of the genetic liability for lifetime smoking heaviness on CAD was attenuated (OR:1.38 (95% CI:0.99,1.92)) (Table S9) , which supports an effect of genetic liability for ADHD on CAD independent of genetic liability to lifetime smoking heaviness.
DISCUSSION
In this study, we employed a two-sample MR approach to test for causal effects of genetic liability for ADHD on previously implicated physical health outcomes. By using genetic variants to proxy for ADHD, we found evidence consistent with a causal effect of genetic liability for ADHD on coronary artery disease (CAD) and evidence for a bidirectional association between genetic liability for ADHD and childhood obesity. There was little evidence for a causal effect on neurological and immunological diseases. The causal effect of genetic liability for ADHD on CAD appears to be (at least partially) mediated by childhood obesity and independent of lifetime smoking.
As reported previously ADHD and genetic liability for ADHD are associated with unhealthy lifestyle and risk behaviours in observational studies (12, (37) (38) (39) Although MR can overcome some limitations of observational studies, it also makes strong assumptions that cannot always be tested. We therefore highly encourage triangulation of evidence using different causally informative study designs, such as negative control and twin studies ( 4 9 ) .
Conclusion
We found evidence in favour of a causal effect of genetic liability for ADHD on CAD that is potentially mediated by childhood obesity. This strengthens the argument for early treatment and support for children with ADHD and their families and especially promoting physical activity and providing them with dietary advice and support to reduce the future risk for developing obesity and CAD.
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